Company Profile
Novalgen Limited
11621264•Private Limited With Share Capital
Get Full Access
14/10/2018
7 years
7
8
72110
moderate risk
Company Overview
Registration, classification & business activity
Novalgen Limited (11621264) is a private limited with share capital incorporated on 14/10/2018 (7 years old) and registered in northwood hills, HA61NW. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Novalgen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. novalgen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by deve...
Financial Overview
£4.90M
£1.37M
£3.53M
£3.09M
£1.37M
Key Metrics
8
Employees
7
Directors
14
Shareholders
Board of Directors
Innovate Grants
This company received a grant of £590648.0 for First In Class To First In Human: Harnessing Physiological Regulation Mechanisms To Enhance Safety And Efficacy Of Next Generation Bispecific Antibodies. The project started on 01/06/2022 and ended on 30/11/2024.
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating